N. Ogata et al., Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment, AM J OPHTH, 132(3), 2001, pp. 378-382
PURPOSE: To report the levels of pigment epithelium-derived factor in the v
itreous of patients with diabetic retinopathy, rhegmatogenous retinal detac
hment, and idiopathic macular hole.
METHODS: Using enzyme,linked immunosorbent as, say, we measured the levels
of pigment epithelium-derived factor in the vitreous of 34 eyes of 33 patie
nts who underwent vitrectomy for the treatment of diabetic retinopathy (17
eyes of 16 patients), rhegmatogenous retinal detachment (10 eyes), and idio
pathic macular hole (seven eyes).
RESULTS: The vitreal concentration of pigment epithelium-derived factor was
1.15 +/- 0.23 mug/ml (mean +/- standard error) in eyes with diabetic retin
opathy, 3.28 +/- 0.69 mug/ml in rhegmatogenous retinal detachment, and 1.71
+/- 0.39 mug/ml in idiopathic macular hole. The pigment epithelium-derived
factor level in rhegmatogenous retinal detachment was significantly higher
than that in diabetic retinopathy (P = .0008) and idiopathic macular hole
(P = .034). For eyes with diabetic retinopathy, the pigment epithelium-deri
ved factor level was 0.88 +/- 0.21 mug/ml in proliferative diabetic retinop
athy and 2.43 +/- 0.37 mug/ml in nonproliferative diabetic retinopathy (P =
.0083). Additionally, the pigment epithelium-derived factor level in activ
e diabetic retinopathy (0.70 +/- 0.22 mug/ml) was significantly lower than
the level in inactive diabetic retinopathy (1.79 +/- 0.35 mug/ml; P = .018)
.
CONCLUSIONS: These results suggest that pigment epithelium-derived factor i
nhibits angiogenesis and that lower levels of pigment epithelium-derived fa
ctor may be related to the angiogenesis in diabetic retinopathy and result
in active proliferative diabetic retinopathy. The results also suggest that
higher levels of pigment epithelium-derived factor in the eyes with rhegma
togenous retinal detachment may act as a neuroprotective agent for the deta
ched retina. (Am J Ophthalmol 2001;132: 378-382. (C) 2001 by Elsevier Scien
ce Inc. All rights reserved.).